Myda Advisors LLC Aslan Pharmaceuticals LTD Transaction History

Myda Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.74 - $1.22 $14,800 - $24,400	-20,000 Reduced 11.76%	150,000 $135,000
Q4 2021 Feb 11, 2022	SELL	$1.11 - $1.86 $73,443 - $123,066	-66,165 Reduced 28.02%	170,000 $190,000
Q3 2021 Nov 12, 2021	BUY	$1.78 - $3.41 $44,500 - $85,250	25,000 Added 11.84%	236,165 $420,000
Q2 2021 Aug 13, 2021	BUY	$2.5 - $3.72 $27,912 - $41,533	11,165 Added 5.58%	211,165 $697,000
Q1 2021 May 12, 2021	BUY	$1.86 - $5.25 $372,000 - $1.05 Million	200,000 New	200,000 $670,000
Q4 2018 Feb 12, 2019	SELL	$2.86 - $8.0 $28,600 - $80,000	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$7.3 - $8.5 $86,870 - $101,150	-11,900 Reduced 54.34%	10,000 $80,000
Q2 2018 Aug 13, 2018	BUY	$5.48 - $10.24 $120,012 - $224,256	21,900 New	21,900 $195,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.